Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Chapman

Showing results (311-320 of 597) with videos related to

Pageof 60
Sort By:
International Journal of Technology Assessment in Health Care|May 18, 2000
Measuring costs in cost-utility analyses. Variations in the literatureP W Stone, R H Chapman, E A Sandberg, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340H Chapman, M Kernan, E Prisbe, et al.
Journal of Medical Economics|April 27, 2012
Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysisElise M Pelletier, Manjiri Pawaskar, Paula J Smith, et al.
BMC Health Services Research|September 29, 2011
Clinicians adopting evidence based guidelines: a case study with thromboprophylaxisNicola H Chapman, Steven P Lazar, Margaret Fry, et al.
Neurosurgery|June 19, 1998
Stereotactic radiosurgery for cavernous malformations: Kjellberg's experience with proton beam therapy in 98 cases at the Harvard CyclotronS Amin-Hanjani, C S Ogilvy, G J Candia, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 4, 2000
A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studiesR H Chapman, P W Stone, E A Sandberg, et al.
Journal of Biomedical Optics|January 5, 2011
Angular domain transillumination imaging optimization with an ultrafast gated cameraFartash Vasefi, Mohamadreza Najiminaini, Eldon Ng, et al.
Pharmacoeconomics|May 3, 2019
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States"R Brett McQueen, Melanie D Whittington, Rick H Chapman, et al.
Health Affairs (Project Hope)|March 16, 2000
Are pharmaceuticals cost-effective? A review of the evidenceP J Neumann, E A Sandberg, C M Bell, et al.
The Western Journal of Medicine|March 1, 1975
Myelodysplasia. Problems of long-term survival and social functionD B Shurtleff, P W Hayden, W H Chapman, et al.
Pageof 60

Showing results (311-320 of 597) with videos related to

Sort By:
Pageof 60
International Journal of Technology Assessment in Health Care|May 18, 2000
Measuring costs in cost-utility analyses. Variations in the literatureP W Stone, R H Chapman, E A Sandberg, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Practical synthesis, separation, and stereochemical assignment of the PMPA pro-drug GS-7340H Chapman, M Kernan, E Prisbe, et al.
Journal of Medical Economics|April 27, 2012
Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysisElise M Pelletier, Manjiri Pawaskar, Paula J Smith, et al.
BMC Health Services Research|September 29, 2011
Clinicians adopting evidence based guidelines: a case study with thromboprophylaxisNicola H Chapman, Steven P Lazar, Margaret Fry, et al.
Neurosurgery|June 19, 1998
Stereotactic radiosurgery for cavernous malformations: Kjellberg's experience with proton beam therapy in 98 cases at the Harvard CyclotronS Amin-Hanjani, C S Ogilvy, G J Candia, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 4, 2000
A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studiesR H Chapman, P W Stone, E A Sandberg, et al.
Journal of Biomedical Optics|January 5, 2011
Angular domain transillumination imaging optimization with an ultrafast gated cameraFartash Vasefi, Mohamadreza Najiminaini, Eldon Ng, et al.
Pharmacoeconomics|May 3, 2019
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States"R Brett McQueen, Melanie D Whittington, Rick H Chapman, et al.
Health Affairs (Project Hope)|March 16, 2000
Are pharmaceuticals cost-effective? A review of the evidenceP J Neumann, E A Sandberg, C M Bell, et al.
The Western Journal of Medicine|March 1, 1975
Myelodysplasia. Problems of long-term survival and social functionD B Shurtleff, P W Hayden, W H Chapman, et al.
Pageof 60